| 发明名称 |
NOVEL AGENTS FOR THE TREATMENT OF DISORDERS CONNECTED TO IMPAIRED NEUROTRANSMISSION |
| 摘要 |
The present invention relates to the use of oregano extracts and their volatile components for the treatment of disorders connected to impaired neurotransmission in animals including humans as well as to dietary supplements, food and feed or pharmaceutical compositions containing such extracts or their volatile components |
| 申请公布号 |
EP2049132(A1) |
申请公布日期 |
2009.04.22 |
| 申请号 |
EP20070801575 |
申请日期 |
2007.08.09 |
| 申请人 |
DSM IP ASSETS B.V. |
发明人 |
FOWLER, ANN;GORALCZYK, REGINA;KILPERT, CLAUS;SCHUELER, GOEDE |
| 分类号 |
A61K36/53;A61P25/24 |
主分类号 |
A61K36/53 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
